30 July 2019

Bart Kiemeny is on stage in his Radboudumc cycling outfit, 3500 kilometers in his legs and surrounded by podium girls of ‘Daags na de Tour’. Because yes, professor Bart Kiemeney cycled the Tour de France. For more money on cancer research.

With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. Not only did he get close to his target amount (you can still donate!), but Bart was also one of the few to have covered the entire course of this edition of the Tour de France.

 "Now I'm really not going to cycle the Tour anymore!” the professor writes in his epilogue.
 

Bart's Tour de France

Read the entire epilogue on www.tourdefrancevanbart.nl or donate.
That's still possible!

Related news items


Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano

23 September 2020

Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 700K euros to study the cancer cell surface in immunotherapy.

read more

Tumor cells stimulate lipid biosynthesis in macrophages

23 September 2020

RIMLS researchers wrote in the Journal for ImmunoTherapy of Cancer that improved lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics.

read more

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genomics of Neurodevelopmental Disorders

17 September 2020

Annette Schenck has been appointed professor of Translational Genomics of Neurodevelopmental Disorders. with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more